检索结果 - C. Tosello

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer

    Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic... 由 G Brufman, E Colajori, N. Ghilezan, M. Lassus, Monica Martoni, Н И Переводчикова, C. Tosello, Donatella Viaro, C. Zielinski

    出版 1997
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

    A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Ta... 由 Henry Gómez, Silvia P. Neciosup, C. Tosello, Max S. Mano, José Bines, Gustavo Ismael, Patrícia Xavier Santi, Hélio Pinczowski, Yeni Nerón, Marcello Ferretti Fanelli, Luis Fein, Carlos Sampaio, Guillermo Lerzo, Adolfo Capó, Juan José Zarbá, C. Blajman, Mirta Varela, Jeovany Martínez-Mesa, Gustavo Werutsky, Carlos H. Barrios

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: